CNK vs RGC vs NUVB vs AMC

For growth investors, Nuvation Bio Inc.

(NUVB) is the stronger pick with 699. 0% revenue growth year-over-year, versus 2. 1% for Cinemark Holdings, Inc. (CNK). Cinemark Holdings, Inc. (CNK) offers the better valuation at 26. 4x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Cinemark Holdings, Inc. (CNK) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Regencell Bioscience Holdings Limited (RGC) delivered a total return of +112.

9%, compared to -98. 4% for AMC Entertainment Holdings, Inc. (AMC). Over 10 years, the gap is even starker: RGC returned +119. 3% versus AMC's -84. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cinemark Holdings, Inc.

(CNK) is the lower-risk stock at 0. 22β versus Nuvation Bio Inc. 's 2. 04β — meaning NUVB is approximately 836% more volatile than CNK relative to the S&P 500. On balance sheet safety, Regencell Bioscience Holdings Limited (RGC) carries a lower debt/equity ratio of 1% versus 9% for Cinemark Holdings, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Nuvation Bio Inc.

(NUVB) is pulling ahead at 699. 0% versus 2. 1% for Cinemark Holdings, Inc. (CNK). On earnings-per-share growth, the picture is similar: Nuvation Bio Inc. grew EPS 71. 6% year-over-year, compared to -49. 5% for Cinemark Holdings, Inc.. Over a 3-year CAGR, CNK leads at 8. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Cinemark Holdings, Inc.

(CNK) is the more profitable company, earning 4. 4% net margin versus -325. 3% for Nuvation Bio Inc. — meaning it keeps 4. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMC leads at 38. 1% versus -338. 7% for NUVB. At the gross margin level — before operating expenses — NUVB leads at 86. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for NUVB: 157.

3% to $12. 40.

In this comparison, CNK (1.

1% yield) pays a dividend. RGC, NUVB, AMC do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Cinemark Holdings, Inc.

(CNK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 22), 1. 1% yield). Nuvation Bio Inc. (NUVB) carries a higher beta of 2. 04 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CNK: -6. 6%, NUVB: -51. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CNK (Communication Services) and RGC (Healthcare) and NUVB (Healthcare) and AMC (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CNK is a small-cap quality compounder stock; RGC is a mid-cap quality compounder stock; NUVB is a small-cap high-growth stock; AMC is a small-cap quality compounder stock. CNK pays a dividend while RGC, NUVB, AMC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.